ORCL stock · ORMP stock

ORCL vs ORMP

Oracle Corporation (ORCL) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.

Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.

Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.

Latest reported ORCL revenue for 2025-05-31 was $57.40B. Net income was $12.63B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.

Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.

ORCL currently screens at market cap $527.84B and trailing P/E 31.4. ORMP currently screens at market cap $87.2M.

Not investment advice. Open the ORCL and ORMP stock pages for the full models.

Not investment advice.

Popular Stock Comparisons